Background illustration for clinical trials search

Paid Clinical Trials Worcester

Discover 3,097 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

for
Triple Negative Breast Cancer, Breast Cancer,
Location: Boston MA, New York NY, Fairfax VA, Detroit MI,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05377996

Phase1, Phase2, Recruiting

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

for
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06122896

Early_phase1, Recruiting

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors
Location: Boston MA, Providence RI, Mineola NY, Hackensack NJ,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05836324

Phase1, Recruiting

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

for
Monoclonal Gammopathy of Undetermined Significance (MGUS),
Location: Boston MA, Stony Brook NY, New York NY, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06140524

Phase2, Recruiting

Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors

for
Advanced Malignant Solid Neoplasm,
Location: Boston MA, Mineola NY, New York NY, Bethesda MD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05687136

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

for
Platinum-resistant Ovarian Cancer, Testicular Cancer,
Location: Boston MA, Providence RI, New York NY, Durham NC,
Sponsor: Context Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06515613

Phase1, Recruiting

Childhood Cancer Predisposition Study (CCPS)

for
Pediatric Cancer
Location: Boston MA, Philadelphia PA, Toronto, Atlanta GA,
Sponsor: Emory University

Sex: All

Age: 0+

Code: NCT04511806

Recruiting

Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients

for
Stem Cell Transplant Complications, Sleep Disturbance
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 9 - 17

Code: NCT06468618

Recruiting

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Boston MA, Buffalo NY, Duarte CA, Irvine CA,
Sponsor: City of Hope Medical Center

Sex: All

Age: 70+

Code: NCT04305834

Phase2, Recruiting

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

for
Basal Ganglia Germinoma, Diabetes Insipidus, Germinoma,
Location: Boston MA, Providence RI, Hartford CT, New Haven CT,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT06368817

Phase2, Recruiting

Statins and Breast Cancer Biomarkers

for
Breast Cancer
Location: Boston MA, Burlington VT, Newark DE, Durham NC,
Sponsor: University of Vermont

Sex: Female

Age: 35 - 55

Code: NCT00914017

Phase2, Recruiting

Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes

for
Genetic Testing, BRCA1/2
Location: Boston MA, Commack NY, Harrison NY, Uniondale NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 25+

Code: NCT03396341

Recruiting

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

for
Advanced Solid Tumor
Location: Boston MA, Montreal, Toronto, Pittsburgh PA,
Sponsor: Senhwa Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04890613

Phase1, Recruiting

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Boston MA, New Haven CT, Long Island City NY,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT06800313

Phase1, Phase2, Recruiting

Exercise in Metastatic Breast Cancer: EMBody

for
Breast Cancer, Indolent Metastatic Breast Cancer
Location: Boston MA, Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT05468034

Recruiting

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

for
B-cell Acute Lymphoblastic Leukemia,
Location: Boston MA, Buffalo NY, Chicago IL
Sponsor: Marlise Luskin, MD

Sex: All

Age: 18+

Code: NCT03595917

Phase1, Recruiting

A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)

for
Gastrointestinal Stromal Tumor (GIST)
Location: Boston MA, New York NY, Grand Rapids MI, Nashville TN,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06630234

Phase1, Phase2, Recruiting

REtroperitoneal SArcoma Registry: an International Prospective Initiative

for
Retroperitoneal Sarcoma
Location: Boston MA, Ottawa, Toronto, Columbus OH, Emory GA,
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Sex: All

Age: 18+

Code: NCT03838718

Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

for
Advanced Solid Tumors, HER2 Mutation
Location: Boston MA, Toronto, Cleveland OH, Nashville TN,
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06760819

Phase2, Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

for
Colorectal Carcinoma, Endometrial Carcinoma, Melanoma,
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT04851119

Phase1, Phase2, Recruiting